Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (71-80 of 376) with videos related to

Pageof 38
Sort By:
Antimicrobial Agents and Chemotherapy|January 26, 2026
Protein binding of vancomycin in a large mixed patient population at a university hospitalAlexander Dejaco, Constantin Lier, Sabrina Krautbauer, et al.
Journal of Lipid Research|July 20, 2012
The PCSK9 decadeGilles Lambert, Barbara Sjouke, Benjamin Choque, et al.
Journal of the American College of Cardiology|July 16, 2016
Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause MortalityJoost Besseling, G Kees Hovingh, Roeland Huijgen, et al.
Circulation Research|January 4, 2014
Novel therapies focused on the high-density lipoprotein particleJulian C van Capelleveen, H Bryan Brewer, John J P Kastelein, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2014
Unbound fraction of ertapenem in intensive care unit patientsUwe Liebchen, Alexander Kratzer, Sebastian G Wicha, et al.
Drugs|January 24, 2024
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the LiteratureWillemijn A M Schonck, Erik S G Stroes, G Kees Hovingh, et al.
The American Journal of Cardiology|November 10, 2009
The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approachesAart C Strang, G Kees Hovingh, Erik S G Stroes, et al.
Journal of Clinical Pharmacology|January 21, 2015
Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infectionsSebastian G Wicha, Thomas Haak, Karl Zink, et al.
Current Opinion in Lipidology|July 9, 2008
The value of HDL geneticsAdriaan G Holleboom, Menno Vergeer, G Kees Hovingh, et al.
Frontiers in Pharmacology|February 16, 2024
Determination of glomerular filtration rate "en passant" after high doses of iohexol for computed tomography in intensive care medicine-a proof of conceptAlexander Dejaco, Christoph Dorn, Michael Paal, et al.
Pageof 38

Showing results (71-80 of 376) with videos related to

Sort By:
Pageof 38
Antimicrobial Agents and Chemotherapy|January 26, 2026
Protein binding of vancomycin in a large mixed patient population at a university hospitalAlexander Dejaco, Constantin Lier, Sabrina Krautbauer, et al.
Journal of Lipid Research|July 20, 2012
The PCSK9 decadeGilles Lambert, Barbara Sjouke, Benjamin Choque, et al.
Journal of the American College of Cardiology|July 16, 2016
Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause MortalityJoost Besseling, G Kees Hovingh, Roeland Huijgen, et al.
Circulation Research|January 4, 2014
Novel therapies focused on the high-density lipoprotein particleJulian C van Capelleveen, H Bryan Brewer, John J P Kastelein, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2014
Unbound fraction of ertapenem in intensive care unit patientsUwe Liebchen, Alexander Kratzer, Sebastian G Wicha, et al.
Drugs|January 24, 2024
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the LiteratureWillemijn A M Schonck, Erik S G Stroes, G Kees Hovingh, et al.
The American Journal of Cardiology|November 10, 2009
The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approachesAart C Strang, G Kees Hovingh, Erik S G Stroes, et al.
Journal of Clinical Pharmacology|January 21, 2015
Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infectionsSebastian G Wicha, Thomas Haak, Karl Zink, et al.
Current Opinion in Lipidology|July 9, 2008
The value of HDL geneticsAdriaan G Holleboom, Menno Vergeer, G Kees Hovingh, et al.
Frontiers in Pharmacology|February 16, 2024
Determination of glomerular filtration rate "en passant" after high doses of iohexol for computed tomography in intensive care medicine-a proof of conceptAlexander Dejaco, Christoph Dorn, Michael Paal, et al.
Pageof 38